151 related articles for article (PubMed ID: 17920356)
1. Differences in utilization of drug-eluting stents by race and payer.
Hannan EL; Racz M; Walford G; Clark LT; Holmes DR; King SB; Sharma S
Am J Cardiol; 2007 Oct; 100(8):1192-8. PubMed ID: 17920356
[TBL] [Abstract][Full Text] [Related]
2. African-American patients are less likely to receive drug-eluting stents during percutaneous coronary intervention.
Gaglia MA; Shavelle DM; Tun H; Bhatt J; Mehra A; Matthews RV; Clavijo L
Cardiovasc Revasc Med; 2014 Jun; 15(4):214-8. PubMed ID: 24814420
[TBL] [Abstract][Full Text] [Related]
3. Insurance type influences the use of drug-eluting stents.
Gaglia MA; Torguson R; Xue Z; Gonzalez MA; Collins SD; Ben-Dor I; Syed AI; Maluenda G; Delhaye C; Hanna N; Wakabayashi K; Kaneshige K; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
JACC Cardiovasc Interv; 2010 Jul; 3(7):773-9. PubMed ID: 20650440
[TBL] [Abstract][Full Text] [Related]
4. Disparities in the Use of Drug-Eluting Coronary Stents by Race, Ethnicity, Payer, and Hospital.
Hannan EL; Racz MJ; Walford G; Jacobs AK; Stamato NJ; Gesten F; Berger PB; Sharma S; King SB
Can J Cardiol; 2016 Aug; 32(8):987.e25-31. PubMed ID: 27177835
[TBL] [Abstract][Full Text] [Related]
5. Variations in the use of an innovative technology by payer: the case of drug-eluting stents.
Epstein AJ; Ketcham JD; Rathore SS; Groeneveld PW
Med Care; 2012 Jan; 50(1):1-9. PubMed ID: 22167062
[TBL] [Abstract][Full Text] [Related]
6. Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction.
Hannan EL; Racz M; Walford G; Holmes DR; Jones RH; Sharma S; Katz S; King SB
JACC Cardiovasc Interv; 2008 Apr; 1(2):129-35. PubMed ID: 19463290
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting versus bare-metal stents in unprotected left main coronary artery stenosis a meta-analysis.
Pandya SB; Kim YH; Meyers SN; Davidson CJ; Flaherty JD; Park DW; Mediratta A; Pieper K; Reyes E; Bonow RO; Park SJ; Beohar N
JACC Cardiovasc Interv; 2010 Jun; 3(6):602-11. PubMed ID: 20630453
[TBL] [Abstract][Full Text] [Related]
8. Selection of patients for drug-eluting stents based on insurance coverage: pay or don't play.
Krone RJ
JACC Cardiovasc Interv; 2010 Jul; 3(7):780-2. PubMed ID: 20650441
[No Abstract] [Full Text] [Related]
9. Time dependency of outcomes for drug-eluting vs bare-metal stents.
Leung AA; Southern DA; Galbraith PD; Knudtson ML; Philpott AC; Ghali WA;
Can J Cardiol; 2013 Dec; 29(12):1616-22. PubMed ID: 24267804
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Cost of Drug-Eluting Stents versus Bare Metal Stents in the Treatment of Critical Limb Ischemia in the United States.
Locham SS; Paracha N; Dakour-Aridi H; Nejim B; Rizwan M; Malas MB
Ann Vasc Surg; 2019 Feb; 55():55-62.e2. PubMed ID: 30092444
[TBL] [Abstract][Full Text] [Related]
11. Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual?
Wang FW; Uretsky BF; Freeman JL; Zhang D; Giordano SH; Goodwin JS
Catheter Cardiovasc Interv; 2008 Apr; 71(5):636-43. PubMed ID: 18360856
[TBL] [Abstract][Full Text] [Related]
12. Predictors and variability of drug-eluting vs bare-metal stent selection in contemporary percutaneous coronary intervention: Insights from the PRISM study.
Shafiq A; Gosch K; Amin AP; Ting HH; Spertus JA; Salisbury AC
Clin Cardiol; 2017 Aug; 40(8):521-527. PubMed ID: 28300284
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
[TBL] [Abstract][Full Text] [Related]
14. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B
Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969
[TBL] [Abstract][Full Text] [Related]
15. Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked National Cardiovascular Data Registry and centers for Medicare & Medicaid services payer databases.
Kumar RS; Douglas PS; Peterson ED; Anstrom KJ; Dai D; Brennan JM; Hui PY; Booth ME; Messenger JC; Shaw RE
Circulation; 2013 Apr; 127(13):1395-403. PubMed ID: 23547179
[TBL] [Abstract][Full Text] [Related]
16. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous coronary intervention and drug-eluting stent use among patients ≥85 years of age in the United States.
Wang TY; Masoudi FA; Messenger JC; Shunk KA; Boyle A; Brennan JM; Anderson HV; Anstrom KJ; Dai D; Peterson ED; Douglas PS; Rumsfeld JS
J Am Coll Cardiol; 2012 Jan; 59(2):105-12. PubMed ID: 22222072
[TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
[TBL] [Abstract][Full Text] [Related]
19. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.
Pfisterer M; Brunner-La Rocca HP; Buser PT; Rickenbacher P; Hunziker P; Mueller C; Jeger R; Bader F; Osswald S; Kaiser C;
J Am Coll Cardiol; 2006 Dec; 48(12):2584-91. PubMed ID: 17174201
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008.
Patel MR; Marso SP; Dai D; Anstrom KJ; Shunk KA; Curtus JP; Brennan JM; Sedrakyan A; Messenger JC; Douglas PS
JACC Cardiovasc Interv; 2012 Oct; 5(10):1054-61. PubMed ID: 23078736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
